Develops biotechnology solutions for autoimmune diseases and cancer, focusing on novel immunotherapies.
Telesis Bio Inc., originally Codex DNA, Inc., is a pioneering synthetic biology company based in San Diego, California. Specializing in the development and distribution of cutting-edge synthetic biology instruments, reagents, and associated products, Telesis Bio serves a global customer base that includes pharmaceutical companies, academic laboratories, government institutions, and synthetic biology firms.
Central to Telesis Bio's offerings is the BioXp system, a revolutionary platform enabling researchers to seamlessly translate digital DNA sequences into fully synthesized DNA. The system is complemented by the BioXp portal, an intuitive online platform that facilitates streamlined workflow and design tools for constructing new DNA sequences and assembling them into desired vectors. Additionally, the company provides BioXp kits containing essential reagents and Gibson Assembly branded components, supporting various synthetic biology applications.
Founded in 2011, Telesis Bio has expanded its capabilities beyond product offerings to include Biofoundry Services. This service enables customers to order and receive endpoint-ready synthetic DNA products such as genes, clones, and variant libraries, tailored to meet specific research needs. With its commitment to innovation and comprehensive solutions, Telesis Bio continues to drive advancements in synthetic biology, empowering researchers worldwide to accelerate their scientific discoveries.